Asperosaponin VI, A Saponin Component from Dipsacus asper Wall, induces Osteoblast Differentiation through Bone Morphogenetic Protein‐2/p38 and Extracellular Signal‐regulated Kinase 1/2 Pathway
Authors:
- 31 March 2011
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 25 (11) , 1700-1706
Abstract
Osteoporosis is a reduction in skeletal mass because of the loss of osteoblastic activity or an increase in osteoclastic activity. The survival of osteoblast cells plays a crucial role in the development of osteoporosis. Asperosaponin VI (ASA VI) is a kind of saponin in the medicinal herb Dipsacus asper Wall which has long been used as an antiosteoporosis drug. The assay of cell proliferation, alkaline phosphatase (ALP) activity and measurement of mineralized matrix, showed that ASA VI exhibited a significant induction of proliferation, differentiation and mineralization in MC3T3‐E1 and primary osteoblastic cells. Induction of differentiation by ASA VI was associated with increased bone morphogenetic protein‐2 (BMP‐2), indicating that BMP‐2 is essential in ASA VI to mediate osteoblast maturation and differentiation. In addition, ASA VI may induce differentiation by increasing the activity of p38 and ERK1/2. In conclusion, ASA VI may induce osteoblast maturation and differentiation, and then increase bone formation via increasing BMP‐2 synthesis, and activating p38 and ERK1/2. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- Mechanisms of Anabolic Therapies for OsteoporosisNew England Journal of Medicine, 2007
- Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper WallJournal of Ethnopharmacology, 2006
- Phosphophoryn Regulates the Gene Expression and Differentiation of NIH3T3, MC3T3-E1, and Human Mesenchymal Stem Cells via the Integrin/MAPK Signaling PathwayJournal of Biological Chemistry, 2004
- Activation of p38 Mitogen-Activated Protein Kinase and c-Jun-NH2-Terminal Kinase by BMP-2 and Their Implication in the Stimulation of Osteoblastic Cell DifferentiationJournal of Bone and Mineral Research, 2003
- Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK)Molecular and Cellular Biochemistry, 2003
- Activation of p38 Mitogen-Activated Protein Kinase Is Required for Osteoblast DifferentiationEndocrinology, 2003
- Bone Morphogenetic Proteins, Their Antagonists, and the SkeletonEndocrine Reviews, 2003
- Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) productionBiochemical Pharmacology, 2003
- Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cellsBone, 2001
- Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-activated Protein KinaseJournal of Biological Chemistry, 2000